Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2025-12-15
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
i. Impact of Event Scale - Revised (IES-R) is a 22-item test that measures the level of stress and anxiety resulting from traumatic events. It is utilized as a screening tool in diagnosing post-traumatic stress disorder (PTSD). The test consists of 22 questions that relate to the respondent's feelings, behaviors, and thoughts concerning the traumatic event over the past seven days. For each question, respondents will indicate one of five responses that best reflects their experience: 0 - Not at all
1. \- A little
2. \- Moderately
3. \- Often
4. \- Very often
Upon completion of all questions and totaling the points, the scale for symptoms is classified as follows:
0-23 points: No or mild symptoms 24-32 points: A significant number of symptoms 33 points or more: Most symptoms characteristic of PTSD. The questionnaire will be completed during hospitalization.
ii. Posttraumatic Stress Disorder Checklist - Specific (PCL-S) is a 17-item test designed to detect symptoms of PTSD resulting from a specific traumatic event. This test includes 17 questions related to the behaviors and feelings of the respondent over the past month. Each question is answered using a 5-point scale with assigned points: Not at all - 1 point Sometimes - 2 points Moderately often - 3 points Often - 4 points Very often - 5 points
After totaling the points, they are classified as follows:
17-29 points: No or few PTSD symptoms 30-44 points: Moderate to moderately high PTSD symptoms 45-85 points: Numerous PTSD symptoms. The questionnaire will be completed during a routine follow-up visit at the outpatient clinic eight weeks post-discharge from the hospital.
iii. Trauma Recovery Measure (TRM) is a 15-item tool designed to assess trauma and the recovery process. It enables a structured evaluation of the multifaceted impact of trauma on an individual, facilitating the adjustment of support and intervention strategies.
The TRM provides a total score as well as three subscale scores that assess the cognitive aspects of the individual following the experience of traumatic events. The three subscales within the TRM include:
* Validation: This subscale measures the acceptance and self-acceptance of the trauma survivor as they are, despite the traumatic experience, and evaluates the development of internal worth and dignity.
* Liberation: This subscale assesses the survivor's ability to free themselves from control, entrapment, and/or oppression caused by the trauma, and their capacity to live in a way that allows them to feel empowered and confident in making positive decisions for themselves and others.
* Positive Self: This subscale measures the presence of positive cognitive aspects that generate feelings of care, compassion, and/or kindness.
The stage of recovery is presented based on the distance of the score from the mean. There are three possible stages of recovery:
* Early Stage of Recovery: Less than 1 standard deviation below the mean (total score of 31 or fewer).
* Middle Stage of Recovery: Total score ranging from 32 to 61.
* Late Stage of Recovery: More than 1 standard deviation above the mean (total score of 62 or more).
The questionnaire will be completed during a routine follow-up visit at the outpatient clinic eight weeks post-discharge from the hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women who experienced a spontaneous miscarriage during the first trimester of pregnancy
Recruitment will take place at the Department of Endocrinology and Gynecology at the University Hospital in Kraków, located at ul. Kopernika 23, 31-501 Kraków, and at the Department of Gynecology and Gynecological Oncology NSSU, located at Jakubowskiego 2, 30-688 Kraków. The study plans to enroll 200 women aged 18 to 45 years who have been hospitalized due to a spontaneous miscarriage.
Impact of Event Scale - Revised (IES-R) questionnaire
The test consists of 22 questions that relate to the respondent's feelings, behaviors, and thoughts concerning the traumatic event over the past seven days. For each question, respondents will indicate one of five responses that best reflects their experience:
0 - Not at all
1. \- A little
2. \- Moderately
3. \- Often
4. \- Very often
Upon completion of all questions and totaling the points, the scale for symptoms is classified as follows:
0-23 points: No or mild symptoms 24-32 points: A significant number of symptoms 33 points or more: Most symptoms characteristic of PTSD.
Posttraumatic Stress Disorder Checklist - Specific (PCL-S) questionnaire
This test includes 17 questions related to the behaviors and feelings of the respondent over the past month. Each question is answered using a 5-point scale with assigned points:
Not at all - 1 point Sometimes - 2 points Moderately often - 3 points Often - 4 points Very often - 5 points
After totaling the points, they are classified as follows:
17-29 points: No or few PTSD symptoms 30-44 points: Moderate to moderately high PTSD symptoms 45-85 points: Numerous PTSD symptoms.
Trauma Recovery Measure (TRM) questionnaire
The stage of recovery is presented based on the distance of the score from the mean. There are three possible stages of recovery:
* Early Stage of Recovery: Less than 1 standard deviation below the mean (total score of 31 or fewer).
* Middle Stage of Recovery: Total score ranging from 32 to 61.
* Late Stage of Recovery: More than 1 standard deviation above the mean (total score of 62 or more).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Impact of Event Scale - Revised (IES-R) questionnaire
The test consists of 22 questions that relate to the respondent's feelings, behaviors, and thoughts concerning the traumatic event over the past seven days. For each question, respondents will indicate one of five responses that best reflects their experience:
0 - Not at all
1. \- A little
2. \- Moderately
3. \- Often
4. \- Very often
Upon completion of all questions and totaling the points, the scale for symptoms is classified as follows:
0-23 points: No or mild symptoms 24-32 points: A significant number of symptoms 33 points or more: Most symptoms characteristic of PTSD.
Posttraumatic Stress Disorder Checklist - Specific (PCL-S) questionnaire
This test includes 17 questions related to the behaviors and feelings of the respondent over the past month. Each question is answered using a 5-point scale with assigned points:
Not at all - 1 point Sometimes - 2 points Moderately often - 3 points Often - 4 points Very often - 5 points
After totaling the points, they are classified as follows:
17-29 points: No or few PTSD symptoms 30-44 points: Moderate to moderately high PTSD symptoms 45-85 points: Numerous PTSD symptoms.
Trauma Recovery Measure (TRM) questionnaire
The stage of recovery is presented based on the distance of the score from the mean. There are three possible stages of recovery:
* Early Stage of Recovery: Less than 1 standard deviation below the mean (total score of 31 or fewer).
* Middle Stage of Recovery: Total score ranging from 32 to 61.
* Late Stage of Recovery: More than 1 standard deviation above the mean (total score of 62 or more).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* gestational age up to 14 weeks.
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Iwona Magdalena Gawron
PhD, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Iwona Gawron, PhD, MD
Role: STUDY_DIRECTOR
Jagiellonian University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jagiellonian University Medical College, Department of Gynecology and Obstetrics
Krakow, Malopolska, Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Iwona M Gawron, MD, PhD
Role: primary
Robert Jach, Prof., PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
118.0043.1.343.2025
Identifier Type: -
Identifier Source: org_study_id